MaxCyte Inc (MXCT)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $122.87M
Last updated: Nov 17, 2026 at 4:15 PM ET
MaxCyte Inc (MXCT) Stock Chart
MaxCyte (MXCT) has a latest price of $1.17 on Nov 17, 2026, 35.2% below its 52-week high of $1.80. Its price fell 25.9% over the past 12 months. The month-end price fell 85.9% over the 5 years through Oct 2026, a compound annual decline of 32.4%.
Price Chart
From Jul 2020 to Oct 2026, its highest month-end close was $17.00 in Jul 2021 and its lowest $0.70 in Mar 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart MXCT with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for MXCT.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 15.8%, and over 6 months it rose 12.5%. The month-end price fell 46.3% over the 3 years through Oct 2026, a compound annual decline of 18.7%.
| Period | Change |
|---|---|
| 1 month | -10.0% |
| 3 months | -15.8% |
| 6 months | +12.5% |
| 12 months | -25.9% |
| 12 months, with dividends | -25.9% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -46.3% | -18.7% |
| 5 years | -85.9% | -32.4% |
Price by Year
Its best calendar year was 2021, when the price rose 525.2%, and its weakest was 2025, when it fell 62.7%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $1.59 | +2.6% |
| 2025 | $1.55 | -62.7% |
| 2024 | $4.16 | -11.5% |
| 2023 | $4.70 | -13.9% |
| 2022 | $5.46 | -46.4% |
| 2021 | $10.19 | +525.2% |
Trading Range
The price is 6.3% below its 50-day average of $1.25 and 9.2% above its 200-day average of $1.07.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $1.17 | |
| 52-week high | $1.80 | -35.2% |
| 52-week low | $0.64 | +82.0% |
| 50-day average | $1.25 | -6.3% |
| 200-day average | $1.07 | +9.2% |
Price Risk
Over 3 years, its largest fall from a peak was 87.4%.
| Measure | Value |
|---|---|
| 1-year beta | 1.43 |
| Largest fall, 1 year | -61.6% |
| Largest fall, 3 years | -87.4% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About MXCT
What is MXCT's 1-year price change?
MaxCyte's price fell 25.9% over the past 12 months. With dividends included, the 12-month total return was -25.9%.
What is MXCT's 5-year price change?
MaxCyte's month-end price fell 85.9% over the 5 years through Oct 2026, a compound annual decline of 32.4%. These figures leave out dividends.
What is MXCT's 52-week high and low?
MaxCyte's 52-week high is $1.80 and its 52-week low is $0.64. Its latest price of $1.17 on Nov 17, 2026 is 35.2% below the high.
What is MXCT's beta?
MaxCyte's 1-year beta against the S&P 500 is 1.43, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 61.6%.
Is the MXCT chart free?
Yes. Advanced Charting for MXCT is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
MXCT pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts